Shandong Pharmaceutical (China) Performance
| 600529 Stock | 24.60 0.41 1.64% |
The entity has a beta of 0.14, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Shandong Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Shandong Pharmaceutical is expected to be smaller as well. At this point, Shandong Pharmaceutical has a negative expected return of -0.19%. Please make sure to validate Shandong Pharmaceutical's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Shandong Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Shandong Pharmaceutical Glass has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Payout Ratio 0.3008 | Last Split Factor 1.4:1 | Ex Dividend Date 2024-10-11 | Last Split Date 2019-06-20 |
1 | There Is A Reason Shandong Pharmaceutical Glass Co.Ltds Price Is Undemanding - Simply Wall St | 12/13/2024 |
| Begin Period Cash Flow | 1.2 B |
Shandong |
Shandong Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,795 in Shandong Pharmaceutical Glass on October 10, 2024 and sell it today you would lose (335.00) from holding Shandong Pharmaceutical Glass or give up 11.99% of portfolio value over 90 days. Shandong Pharmaceutical Glass is generating negative expected returns and assumes 1.8246% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Shandong, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Shandong Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shandong Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shandong Pharmaceutical Glass, and traders can use it to determine the average amount a Shandong Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1019
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 600529 |
Estimated Market Risk
| 1.82 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Shandong Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shandong Pharmaceutical by adding Shandong Pharmaceutical to a well-diversified portfolio.
Shandong Pharmaceutical Fundamentals Growth
Shandong Stock prices reflect investors' perceptions of the future prospects and financial health of Shandong Pharmaceutical, and Shandong Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shandong Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0661 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 13.74 B | ||||
| Shares Outstanding | 663.61 M | ||||
| Price To Book | 2.13 X | ||||
| Price To Sales | 3.18 X | ||||
| Revenue | 4.98 B | ||||
| Gross Profit | 1.12 B | ||||
| EBITDA | 1.35 B | ||||
| Net Income | 775.8 M | ||||
| Total Debt | 1.83 M | ||||
| Book Value Per Share | 11.73 X | ||||
| Cash Flow From Operations | 1.05 B | ||||
| Earnings Per Share | 1.33 X | ||||
| Total Asset | 9.32 B | ||||
| Retained Earnings | 3.58 B | ||||
About Shandong Pharmaceutical Performance
By analyzing Shandong Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Shandong Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shandong Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shandong Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shandong Pharmaceutical is entity of China. It is traded as Stock on SHG exchange.Things to note about Shandong Pharmaceutical performance evaluation
Checking the ongoing alerts about Shandong Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shandong Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shandong Pharmaceutical generated a negative expected return over the last 90 days | |
| Shandong Pharmaceutical is unlikely to experience financial distress in the next 2 years | |
| About 20.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: There Is A Reason Shandong Pharmaceutical Glass Co.Ltds Price Is Undemanding - Simply Wall St |
- Analyzing Shandong Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shandong Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Shandong Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shandong Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shandong Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shandong Pharmaceutical's stock. These opinions can provide insight into Shandong Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shandong Stock analysis
When running Shandong Pharmaceutical's price analysis, check to measure Shandong Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Pharmaceutical is operating at the current time. Most of Shandong Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Shandong Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Pharmaceutical's price. Additionally, you may evaluate how the addition of Shandong Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |